Clinical Development & Late Stage Research

UBC is focused on expanding mobile tactics for clinical trial programs
UBC - December 06, 2013
The second part of my series on mobile health (mHealth), Leveraging Mobile Health through Innovation, focused on expanding the use of mobile tactics for clinical trial programs and highlighted some examples of cutting edge technology...
UBC - December 06, 2013
In order for biopharmaceutical companies to gain product approval, regulatory agencies first require a series of risk evaluations. Clinical trials, for example, may be utilized in the early phases of development in order to prove a...
UBC - November 27, 2013
Time and Motion studies are an appropriate solution when the efficiency of a drug, medical device, or intervention is the outcome of interest. In the current environment of more stringent evidence requirements by regulators and payers...
UBC provides observational study expertise for the Golden Retriever Lifetime Study
UBC - November 20, 2013
More than 50% of golden retrievers over the age of 2 develop cancer — their leading cause of death — with no indication why. A landmark observational study by UBC is working with the Morris Animal Foundation to identify some of these...
UBC helps expand use of mobile tactics for clinical trial programs.
UBC - November 18, 2013
The first part of my series on mobile health (mHealth), Understanding Mobile Health Trends and Opportunities for Clinical Trials and Post-Approval Programs, focused on the basics, along with an overview of the current landscape. Now I...

Pages